Back

A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations

Safonov, A.; Nomakuchi, T. T.; Chao, E.; Horton, C.; Dolinsky, J. S.; Yussuf, A.; Richardson, M.; Speare, V.; Li, S.; Bogus, Z. C.; Bonanni, M.; Raper, A.; Kallish, S.; Ritchie, M. D.; Regeneron Genetics Center, ; Penn Medicine BioBank, ; Nathanson, K. L.; Drivas, T. G.

2023-08-10 genetic and genomic medicine
10.1101/2023.08.08.23293676 medRxiv
Show abstract

Loss of function variants in the NF1 gene cause neurofibromatosis type 1 (NF1), a genetic disorder characterized by complete penetrance, prevalence of 1 in 3,000, characteristic physical exam findings, and a substantially increased risk for malignancy. However, our understanding of the disorder is entirely based on patients ascertained through phenotype-first approaches. Leveraging a genotype-first approach in two large patient cohorts, we demonstrate unexpectedly high prevalence (1 in 450-750) of NF1 pathogenic variants. Half were identified in individuals lacking clinical features of NF1, with many appearing to have post-zygotic mosaicism for the identified variant. Incidentally discovered variants were not associated with classic NF1 features but were associated with an increased incidence of malignancy compared to a control population. Our findings suggest that NF1 pathogenic variants are substantially more common than previously thought, often characterized by somatic mosaicism and reduced penetrance, and are important contributors to cancer risk in the general population.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.